Dermatomyositis and polymyositis (myositis): vizsgálatok itt: Kína
38 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleClinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
- Where
- Hangzhou
- Életkor
- 5 év and over
- People
- 11
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT07184450 - Korai 1. fázisTaking peopleSafety Study of CC312 in Autoimmune Disease Patients
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 18
- Run by
- CytoCares Inc
See details and how to joinNCT06888960 - No phaseTaking peoplePhotoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response Evaluation
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07037472 - Korai 1. fázisNot yet taking people in KínaClinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Peking University People's Hospital
See details and how to joinNCT06986018 - 1. fázisTaking peopleA Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 44
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06980597 - Korai 1. fázisNot yet taking people in KínaEarly Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 15
- Run by
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06970951 - 1. fázisTaking peopleNebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Li Shiyue
See details and how to joinNCT06919380 - 1. fázisTaking peopleClinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)
- Where
- Hangzhou
- Életkor
- 5 év and over
- People
- 18
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06686524 - Korai 1. fázisTaking peopleSafety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Tongji Hospital
See details and how to joinNCT04561557 - 1. fázisTaking peopleClinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
- Where
- Hangzhou
- Életkor
- 5 év to 17 év
- People
- 10
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06569472 - 4. fázisCsak meghívásos3T Therapy in the Treatment of MDA5-positive Dermatomyositis
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 133
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06438679 - No phaseTaking peopleObservational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
- Where
- Beijing, Changsha, Chongqing, Hangzhou, Nanjing, Shenzhen
- Életkor
- Up to 18 év
- People
- 20 000
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06417502 - No phaseTaking peopleMicroecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease
- Where
- Beijing
- Életkor
- 18 év to 100 év
- People
- 50
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT06203249